MLYS
NASDAQ · Biotechnology
Mineralys Therapeutics Inc
$29.26
+2.61 (+9.79%)
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Price Target
Analyst Price Target
+218.5% upside
Low Target
$50.31
Average Target
$93.19
High Target
$121.15
Current Price
$29.26
Current
$29.26
$29.26
Target
$93.19
$93.19
$50.31
$93.19 avg
$121.15
Scenario Analysis
Bear Case
$50.31
71.9%
Low target
Base Case
$93.19
+218.5%
Avg target
Bull Case
$121.15
+314.0%
High target
Risk/Reward
4.4x
Highly favorable
Price in Context
52-Week High
$47.65
-38.6% from high
52-Week Low
$12.59
+132.4% from low
50-Day SMA
$33.44
-12.5% vs SMA
200-Day SMA
$27.93
+4.8% vs SMA
RSI (14)
35.0
Neutral
Target vs 52W High
$93.19
+95.6% vs high
Next Earnings Report
May 18, 2026
8d
until earnings
EPS Est: $-0.47
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 72% | $257.58 | +27.8% |
| AMGN | Hold | 43 | 49% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 26 | 96% | $143.40 | +41.5% |